ArticleThe Utah women's health review2025
Endometriosis and hypertriglyceridemia: Why do we care about severity and typology?
Article in The Utah women's health review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Background: While plausible mechanisms exist for an association between endometriosis and hypertriglyceridemia, prior studies have shown inconsistent findings, possibly due to the inability to assess endometriosis severity or subtypes. Objectives: Among 473 premenopausal individuals undergoing gynecologic laparoscopy, the present study assessed the association between incident endometriosis and non-fasting serum triglycerides. Methods: Participants were recruited (2007-2009) among women undergoing diagnostic or therapeutic laparoscopy or laparotomy (for any indication) and who had no prior endometriosis diagnosis. Endometriosis was categorized using American Society for Reproductive Medicine staging (I-IV). Typology was defined as superficial endometriosis [SE], ovarian endometrioma [OE], and deep infiltrating endometriosis [DE]. We collected biospecimens, anthropometrics, and self-reported sociodemographics at enrollment, prior to surgery. We evaluated the association between endometriosis diagnosis, stage, typology, and triglyceride concentrations using non-fasting female cutpoints (normal <175mg/dL vs hypertriglyceridemia ≥175mg/dL) via generalized linear models. We also evaluated whether the association differed by menstrual cycle phase. Results: Among the cohort, 108 women (23%) had hypertriglyceridemia > 175 mg/dL. Overall, endometriosis was not associated with prevalence of hypertriglyceridemia (adjusted prevalence ratio (aPR): 1.24, 95% CI: 0.87, 1.77), after accounting for baseline age, race/ethnicity, marital status, BMI, income, and serum cotinine. However, this varied by stage and type. Women with moderate to severe stage endometriosis had a higher aPR for hypertriglyceridemia, 1.74 (95% CI: 1.03, 2.95), compared to those without endometriosis. DE combined with OE was associated with a 3.59 higher aPR (95% CI: 2.33, 5.54) for hypertriglyceridemia. A pattern emerged showing stronger associations in the follicular phase compared to the luteal phase. Conclusions: In summary, while no association was observed for overall endometriosis and hypertriglyceridemia, we observed moderate to severe stage endometriosis as well as DE and OE endometriosis was associated with prevalence of hypertriglyceridemia.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.